It is you who do NOT understand personalized medicine.
“.., Anavex Life Sciences is exploring a personalized medicine approach, particularly with its drug blarcamesine (ANAVEX®2-73), by using AI-driven analysis to understand how the drug interacts with individual patient biology and identify potential biomarkers for treatment selection and outcome assessment….”